Validation of a fresh-frozen tissue based prognostic gene signature in formalin-fixed, paraffin-embedded melanomas

Melanoma incidence is rapidly increasing - with a doubling rate of 10-20 years. Precision and reliability of conventional histopathological and clinical staging, however, remain limited in predicting clinical outcome. On the other hand, complementary molecular prognostic markers are not yet availabl